Etiasa 500 mg Sachet

Manufactured byNovartis India Ltd.
ContainsMesalazine
Description

Etiasa 500 mg Sachet is an anti-inflammatory drug used in the treatment of ulcerative colitis, a condition characterized by swelling and scarring of the colon and rectum. It is also used to control the symptoms of ulcerative colitis such as stomach pain, diarrhea, and rectal bleeding.

Substitutes

List of substitutes for Etiasa 500 mg Sachet

Rowasa 500 mg Sachet
Abbott India Ltd.

Side effects

Major & minor side effects for Etiasa 500 mg Sachet

  • Hypersensitivity
  • Abdominal and stomach pain
  • Blurred vision
  • Bloating
  • Headache
  • Irregular heartbeat
  • Hair loss
  • Constipation
  • Dry mouth

Uses of Etiasa 500 mg Sachet

What is it prescribed for?

  • Ulcerative Colitis
Read More
Concerns

Commonly asked questions

  • Onset of action
    The amount of time taken by this medicine to show its effect is subject to vary based on the strength and form of administration.
  • Duration of effect
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Safe with alcohol?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is it habit forming?
    No habit-forming tendencies were reported.
  • Usage in pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Usage while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired side effects is necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to mesalazine or any other components present along with it.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. If the medicine is used, close monitoring of the infant for any undesired side effects is necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
General warnings

Use in pediatrics

The oral form of this medicine is not recommended for use in children under the age of 5 years. The rectal form of this medicine is not recommended for use in children and adolescents.

Geriatric use

Caution is advised while using this medicine in elderly patients due to the increased risk of severe adverse effects.

Use of NSAIDs

Use of NSAIDs along with this medicine may increase the risk of renal impairment. Replacement with a suitable alternative should be considered under your doctor's supervision. It is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with Etiasa 500 mg Sachet to avoid such interactions.

Active peptic ulcer disease

Caution is advised while using this medicine in patients with active peptic ulcer disease due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered under your doctor's supervision.

Missed Dose

The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose. Symptomatic and supportive therapy is warranted in case of an overdose with delayed-release tablets of Etiasa 500 mg Sachet. Overdosage with Etiasa 500 mg Sachet suppository is rare due to limited absorption from the colon.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Tacrolimus

Adefovir

Deferasirox

Botulism immune globulin

Disease interactions

Impaired liver function

Caution is advised while using Etiasa 500 mg Sachet or its prodrugs in patients with an impaired liver function due to the increased risk of severe adverse effects including liver failure. It is recommended to assess the liver function prior to initiating therapy. Close monitoring of liver function may be required based on the clinical condition.

Renal impairment

Caution is advised while using Etiasa 500 mg Sachet or its prodrugs in patients with an impaired renal function due to the increased risk of severe adverse effects including kidney failure. It is recommended to assess the renal function prior to initiating therapy. Close monitoring of renal function may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Etiasa 500 mg Sachet with or without food. Do not take in larger amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Etiasa 500 mg Sachet reduces the symptoms of ulcerative colitis and prevents the worsening of symptoms by blocking the production of certain natural substances in the colon and rectum.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Anti-inflammatory agents, Bowel specific anti-inflammatory aminosalicylate

Schedule

Schedule H

Mesalamine: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 30 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a688021.html

DailyMed - Mesalamine suspension [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 30 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=743ada1c-0f04-43ea-be7d-1560164e6f6e

DailyMed - Asacol- Mesalamine tablet, delayed release [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 30 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82025f6c-471a-456b-ac8d-dd3ca89a004e

DailyMed - Canasa - Mesalamine suppository [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 30 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75fb1efa-d513-4203-8962-6508a24ef3eb

[Internet]. 2017 [cited 30 August 2017]. Available from:

https://www.medicines.org.uk/emc/PIL.18000.latest.pdf

Mesalazine - DrugBank [Internet]. Drugbank.ca. 2017 [cited 30 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB00244

Mesalazine [Internet]. Snomedbrowser.com. 2017 [cited 30 August 2017]. Available from:

http://www.snomedbrowser.com/Codes/Details/387501005
Loading related questions...

How will this medicine affect me?

Chat with verified doctors starting @ ₹99
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Something doesn’t feel right?
Report an error